William Shakespeare

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Bradford Dahms - Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Shakespeare:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. President of Research and Development Common Stock 639,408 $1,950,194 $3.05 06 Nov 2023 Direct
Theseus Pharmaceuticals, Inc. President of Research and Development Restricted Stock Units 21,250 $64,813 $3.05 01 Mar 2023 Direct
Theseus Pharmaceuticals, Inc. President of Research and Development Stock Option (right to buy) 93,260 06 Nov 2023 Direct

Insider Reports Filed by William Shakespeare

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000174502023000060-shakespeare-william-2023-11-06 Theseus Pharmaceuticals, Inc. 06 Nov 2023 2 +$80,347 4 President of Research and Development 07 Nov 2023, 16:03
/report/000110465923027628-shakespeare-william-2023-03-01 Theseus Pharmaceuticals, Inc. 01 Mar 2023 1 $0 4 President of Research and Development 02 Mar 2023, 06:01
/report/000110465923023509-shakespeare-william-2023-02-17 Theseus Pharmaceuticals, Inc. 17 Feb 2023 1 $0 4 President of Research and Development 21 Feb 2023, 06:03
/report/000089924322007497-shakespeare-william-2022-02-18 Theseus Pharmaceuticals, Inc. 18 Feb 2022 1 $0 4 President of Research and Development 23 Feb 2022, 19:00
/report/000089924321040253-shakespeare-william-2021-10-12 Theseus Pharmaceuticals, Inc. 12 Oct 2021 1 +$10,000 4 President of Research and Development 14 Oct 2021, 17:00
/report/000089924321039497-shakespeare-william-2021-10-06 Theseus Pharmaceuticals, Inc. 06 Oct 2021 0 $0 3 President of Research and Development 06 Oct 2021, 19:01